Page last updated: 2024-08-21

thiazoles and 15-deoxyprostaglandin j2

thiazoles has been researched along with 15-deoxyprostaglandin j2 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bradbury, J; Clinton, SK; Guo, Y; Seewaldt, VL; Suster, S; Yee, LD1
LaPointe, MC; Mendez, M1
Evers, BM; Farrow, B; Hashimoto, K; Iwamura, T; O'Connor, KL1
Araki, E; Ishii, N; Itabe, H; Kawada, T; Kim-Mitsuyama, S; Matsumura, T; Motoshima, H; Murata, Y; Nishikawa, T; Senokuchi, T; Taketa, K; Takeya, M; Tsuruzoe, K; Yano, M1

Other Studies

4 other study(ies) available for thiazoles and 15-deoxyprostaglandin j2

ArticleYear
The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells.
    Breast cancer research and treatment, 2003, Volume: 78, Issue:2

    Topics: Apoptosis; Breast; Cell Cycle; Cell Division; Cells, Cultured; Epithelial Cells; Female; Gene Expression; Humans; Hypoglycemic Agents; Ligands; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Thiazoles; Thiazolidinediones; Transcription Factors

2003
PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:4

    Topics: Anilides; Animals; Cells, Cultured; Chromans; Cyclooxygenase 2; Gene Expression Regulation; Interleukin-1; Intramolecular Oxidoreductases; Isoenzymes; Myocytes, Cardiac; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin D2; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

2003
Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.
    Surgery, 2003, Volume: 134, Issue:2

    Topics: Chromans; Humans; Integrins; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Pancreatic Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Tissue Plasminogen Activator; Transcription Factors; Troglitazone; Tumor Cells, Cultured

2003
Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    The Journal of biological chemistry, 2008, Apr-11, Volume: 283, Issue:15

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Gene Expression Regulation, Enzymologic; Humans; Lipoproteins, LDL; Macrophages, Peritoneal; MAP Kinase Signaling System; Meloxicam; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; PPAR alpha; PPAR gamma; Prostaglandin D2; RNA, Messenger; Sulfonamides; Thiazines; Thiazoles

2008